Baird Financial Group, Inc. Novartis Ag Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Baird Financial Group, Inc. holds 89,751 shares of NVS stock, worth $8.83 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

89,751

Previous 87,284 2.83%

Holding current value

$8.83 Million

Previous $9.29 Million 11.1%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $261,822 - $298,235	2,467 Added 2.83%	89,751 $10.3 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $522,465 - $605,996	5,644 Added 6.91%	87,284 $9.29 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $570,286 - $649,301	5,986 Added 7.91%	81,640 $7.9 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $207,238 - $228,058	2,246 Added 3.06%	75,654 $7.64 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $324,544 - $360,175	-3,426 Reduced 4.46%	73,408 $7.48 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $480,641 - $545,007	5,195 Added 7.25%	76,834 $7.75 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $104,119 - $120,745	-1,301 Reduced 1.78%	71,639 $6.59 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $439,676 - $514,223	-5,893 Reduced 6.2%	89,218 $6.78 Million
Q2 2022 Aug 08, 2022	SELL	$80.52 - $93.75 $29,470 - $34,312	-366 Reduced 0.38%	95,111 $8.04 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $330,213 - $373,535	4,122 Added 4.51%	95,477 $8.38 Million
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $15,063 - $16,656	-189 Reduced 0.21%	91,355 $7.99 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $109,830 - $127,773	1,343 Added 1.49%	91,544 $7.49 Million
Q2 2021 Aug 11, 2021	BUY	$85.24 - $94.15 $13,808 - $15,252	162 Added 0.18%	90,201 $8.23 Million
Q1 2021 May 13, 2021	BUY	$83.5 - $98.47 $169,505 - $199,894	2,030 Added 2.31%	90,039 $7.7 Million
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $324,146 - $392,073	4,152 Added 4.95%	88,009 $8.31 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $113,188 - $125,398	1,378 Added 1.67%	83,857 $7.29 Million
Q2 2020 Oct 22, 2020	SELL	$80.93 - $91.1 $93,312 - $105,038	-1,153 Reduced 1.38%	82,479 $7.2 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $642,503 - $723,242	-7,939 Reduced 8.67%	83,632 $7.9 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $642,248 - $899,802	9,088 Added 11.02%	91,571 $7.55 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $210,959 - $238,520	-2,501 Reduced 2.94%	82,483 $7.81 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $1.05 Million - $1.16 Million	-12,315 Reduced 12.66%	84,984 $7.39 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $1.87 Million - $2.3 Million	24,767 Added 34.15%	97,299 $8.88 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $350,237 - $400,597	-4,650 Reduced 6.02%	72,532 $6.97 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $7,366 - $8,202	100 Added 0.13%	77,182 $6.62 Million
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $72,027 - $83,314	-1,076 Reduced 1.38%	77,082 $6.66 Million
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $2.26 Million - $2.56 Million	-34,874 Reduced 30.85%	78,158 $5.9 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $668,845 - $799,593	9,502 Added 9.18%	113,032 $9.14 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $770,676 - $827,254	10,655 Added 11.47%	103,530 $8.69 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $7,191 - $7,495	-97 Reduced 0.1%	92,875 $7.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	92,972	92,972 $7.76 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Novartis Ag Transaction History